QIAGEN N.V. Files Q1 2025 6-K Report
Ticker: QGEN · Form: 6-K · Filed: May 9, 2025 · CIK: 1015820
| Field | Detail |
|---|---|
| Company | Qiagen N.V. (QGEN) |
| Form Type | 6-K |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, foreign-private-issuer, sec-filing
Related Tickers: QGEN
TL;DR
QIAGEN (QGEN) dropped its Q1 2025 6-K filing, check it for updates.
AI Summary
QIAGEN N.V. filed a Form 6-K for the quarterly period ended March 31, 2025. This report is for a foreign private issuer and includes information under 'Other Information', signatures, and an exhibit index. The company's principal executive office is located in Venlo, The Netherlands.
Why It Matters
This filing provides an update on QIAGEN N.V.'s financial reporting for the first quarter of 2025, which is crucial for investors to assess the company's performance and make informed decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing (6-K) and does not appear to contain any significant new disclosures that would immediately alter the company's risk profile.
Key Players & Entities
- QIAGEN N.V. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 001-38332 (other) — Commission File Number
- Venlo, The Netherlands (location) — Principal executive office location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the registrant makes or is required to make public pursuant to the laws of the registrant's home country or jurisdiction, or which the registrant furnishes or is required to furnish to its security holders.
What period does this 6-K filing cover?
This 6-K filing covers the quarterly period ended March 31, 2025.
Where is QIAGEN N.V.'s principal executive office located?
QIAGEN N.V.'s principal executive office is located at Hulsterweg 82, 5912 PL Venlo, The Netherlands.
What is the Commission File Number for QIAGEN N.V.?
The Commission File Number for QIAGEN N.V. is 001-38332.
Does QIAGEN N.V. file an annual report on Form 20-F or 40-F?
QIAGEN N.V. indicates that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 9, 2025 regarding QIAGEN N.V. (QGEN).